2‑FDCK is a dissociative arylcyclohexylamine analog of ketamine, acting primarily as an NMDA receptor antagonist. First synthesized in 2013, it gained attention as a designer analog to ketamine with fluorine-substitution on the phenyl ring, which may alter its pharmacokinetics and binding profile.
Shopping Basket